# A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension

Study · id `cardio:ct-nct03267108` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03267108](<https://clinicaltrials.gov/study/NCT03267108>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03267108

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 145 participants.

## Technical summary

Registry record NCT03267108. Randomized; quadruple masking; primary purpose treatment. Start 2020-12-14 (actual); primary completion 2023-06-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 145 participants (enrolled count; ClinicalTrials.gov record NCT03267108, source copy `cardio:ctgov-nct03267108-2023-07-27`, retrieved 2026-10-31)
- Started: 2020-12-14 (actual) (ClinicalTrials.gov record NCT03267108, source copy `cardio:ctgov-nct03267108-2023-07-27`, retrieved 2026-10-31)
- Primary completion: 2023-06-09 (actual) (ClinicalTrials.gov record NCT03267108, source copy `cardio:ctgov-nct03267108-2023-07-27`, retrieved 2026-10-31)
- Completion: 2023-06-30 (actual) (ClinicalTrials.gov record NCT03267108, source copy `cardio:ctgov-nct03267108-2023-07-27`, retrieved 2026-10-31)
- Countries: United States; Canada (ClinicalTrials.gov record NCT03267108, source copy `cardio:ctgov-nct03267108-2023-07-27`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03267108-2023-07-27`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension
- Acronym: REBUILD
- Condition: Pulmonary Fibrosis
- Condition: Pulmonary Hypertension
- Intervention (Combination product): INOpulse®
- Intervention (Combination product): Placebo
- Intervention (Combination product): Open Label Extension
- Lead sponsor: Bellerophon Pulse Technologies
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Pulmonary hypertension (`cardio:pulmonary-hypertension`)
- Registry lists this organization as the lead sponsor: Bellerophon Pulse Technologies (`cardio:org-bellerophon-pulse-technologies`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Inhaled Nitric Oxide in Fibrotic Lung Disease: A Randomized, Double-Blind, Placebo-controlled Trial (`cardio:pubmed-39141673`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 1be7dc26791748a336b3674a2310acd97dd1e794bf666648a4080c577304a8d2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
